Quest PharmaTech Inc. (QPTFF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.31 Million CAD | -57.73% |
| 2022 | -834.21 Thousand CAD | 98.57% |
| 2021 | -58.3 Million CAD | -135.7% |
| 2020 | 163.31 Million CAD | 1297.8% |
| 2019 | -13.63 Million CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -115.17 Thousand CAD | 67.33% |
| 2024 Q2 | -179.64 Thousand CAD | -55.98% |
| 2023 Q2 | -609.01 Thousand CAD | -208.01% |
| 2023 Q4 | -352.51 Thousand CAD | -125.16% |
| 2023 FY | -1.31 Million CAD | -57.73% |
| 2023 Q1 | -197.72 Thousand CAD | -559.08% |
| 2023 Q3 | -156.56 Thousand CAD | 74.29% |
| 2022 Q3 | -150.11 Thousand CAD | 0.0% |
| 2022 FY | -834.21 Thousand CAD | 98.57% |
| 2022 Q4 | -30 Thousand CAD | 80.02% |
| 2021 FY | -58.3 Million CAD | -135.7% |
| 2020 FY | 163.31 Million CAD | 1297.8% |
| 2019 FY | -13.63 Million CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 98.167% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 126.773% |
| SQZ Biotechnologies Company | -75.82 Million USD | 98.265% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 92.627% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 101.608% |
| Mesoblast Limited | -84.14 Million USD | 98.436% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 14.337% |
| Genus plc | 6.4 Million USD | 120.56% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 113.506% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -41.276% |
| Marizyme, Inc. | -34.08 Million USD | 96.14% |
| ContraFect Corporation | -56.88 Million USD | 97.687% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 84.242% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | 71.111% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 6.146% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | 53.839% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | 52.167% |
| MultiCell Technologies, Inc. | -722.81 USD | -181942.307% |
| Accustem Sciences Inc. | -3.74 Million USD | 64.878% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 97.769% |
| EV Biologics, Inc. | -483.06 Thousand USD | -172.392% |
| Q BioMed Inc. | -3.44 Million USD | 61.812% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 137.17% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -237.762% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | 49.922% |
| Biomind Labs Inc. | -1 Million USD | -30.33% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -4.87 Million USD | 73.034% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | 80.207% |
| Skye Bioscience, Inc. | -13.67 Million USD | 90.376% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | 33.761% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -4293.096% |
| Arch Therapeutics, Inc. | -5.04 Million USD | 73.916% |
| IMV Inc. | -38.67 Million USD | 96.597% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 91.709% |
| Curative Biotechnology, Inc. | -1.93 Million USD | 31.915% |
| GB Sciences, Inc. | -1.42 Million USD | 7.37% |
| Alpha Cognition Inc. | -9.7 Million USD | 86.443% |
| HST Global, Inc. | -140.9 Thousand USD | -833.822% |
| CSL Limited | 3.7 Billion USD | 100.036% |
| Halberd Corporation | -75.05 Thousand USD | -1653.258% |
| Enzolytics Inc. | -2.14 Million USD | 38.765% |
| Resverlogix Corp. | -12.74 Million USD | 89.679% |
| Affymax, Inc. | -15.04 Million USD | 91.255% |
| SYBLEU INC | -149.18 Thousand USD | -782.035% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | 58.469% |
| argenx SE | -425.04 Million USD | 99.69% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 97.629% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -26.036% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | 16.686% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | 61.356% |
| AVAX Technologies, Inc. | 6.69 Million USD | 119.66% |
| Zenith Capital Corp. | -8.94 Million USD | 85.287% |
| Genscript Biotech Corporation | -415.79 Million USD | 99.684% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -7453.068% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | 46.409% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -667.199% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 97.606% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | 54.646% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -33.714% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | 29.423% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -4.763% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 34.365% |
| BioStem Technologies, Inc. | -7.77 Million USD | 83.085% |
| ONE Bio Corp. | 13.68 Million USD | 109.617% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -625.03% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | 1.469% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -16.972% |
| Agentix Corp. | -1.37 Million USD | 4.078% |
| LadRx Corporation | -3.82 Million USD | 65.587% |
| Cell Source, Inc. | -4.32 Million USD | 69.579% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -216.7% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -91.545% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -91.545% |
| NovAccess Global Inc. | -2.46 Million USD | 46.658% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | 54.929% |
| Itoco Inc. | -919.14 Thousand USD | -43.158% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | 68.955% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -17.589% |
| Kadimastem Ltd | -3.04 Million USD | 56.72% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -402.747% |
| CytoDyn Inc. | -18.05 Million USD | 92.713% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -5127.731% |
| Mobile Lads Corp. | -554.55 Thousand USD | -137.277% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -497.888% |
| Qrons Inc. | -643.67 Thousand USD | -104.422% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -133.003% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | 40.991% |
| Rebus Holdings, Inc. | -664 Thousand USD | -98.166% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | 27.556% |
| International Stem Cell Corporation | -663 Thousand USD | -98.465% |
| Bioxytran, Inc. | -3.82 Million USD | 65.556% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -2399.658% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -6369.125% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 96.372% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | 18.676% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -78.82% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | 57.704% |
| Neutra Corp. | -229.48 Thousand USD | -473.377% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 92.498% |
| PureTech Health plc | -146.19 Million USD | 99.1% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 93.877% |
| IXICO plc | -1.43 Million USD | 8.433% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 86.136% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 98.92% |
| CSL Limited | 3.81 Billion USD | 100.035% |
| Cellectis S.A. | -108.85 Million USD | 98.791% |